[go: up one dir, main page]

DK0654991T3 - Inhalationspulver indeholdende antistatisk hjælpemiddel - Google Patents

Inhalationspulver indeholdende antistatisk hjælpemiddel

Info

Publication number
DK0654991T3
DK0654991T3 DK93918018.8T DK93918018T DK0654991T3 DK 0654991 T3 DK0654991 T3 DK 0654991T3 DK 93918018 T DK93918018 T DK 93918018T DK 0654991 T3 DK0654991 T3 DK 0654991T3
Authority
DK
Denmark
Prior art keywords
powder containing
inhalation powder
containing antistatic
antistatic aid
aid
Prior art date
Application number
DK93918018.8T
Other languages
English (en)
Inventor
Gordon Thomas Simpkin
Roy Trunley
Ann-Marie Leighton
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Application granted granted Critical
Publication of DK0654991T3 publication Critical patent/DK0654991T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK93918018.8T 1992-08-14 1993-08-13 Inhalationspulver indeholdende antistatisk hjælpemiddel DK0654991T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9217312A GB2269992A (en) 1992-08-14 1992-08-14 Powder inhalation formulations

Publications (1)

Publication Number Publication Date
DK0654991T3 true DK0654991T3 (da) 1997-12-29

Family

ID=10720370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93918018.8T DK0654991T3 (da) 1992-08-14 1993-08-13 Inhalationspulver indeholdende antistatisk hjælpemiddel

Country Status (16)

Country Link
US (1) US5908639A (da)
EP (1) EP0654991B1 (da)
JP (1) JP3787573B2 (da)
AT (1) ATE154237T1 (da)
AU (1) AU678379B2 (da)
CA (1) CA2142126C (da)
DE (1) DE69311556T2 (da)
DK (1) DK0654991T3 (da)
ES (1) ES2106362T3 (da)
GB (1) GB2269992A (da)
GR (1) GR3024468T3 (da)
IL (1) IL106665A (da)
MX (1) MX9304975A (da)
NZ (1) NZ254945A (da)
WO (1) WO1994004133A1 (da)
ZA (1) ZA935943B (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP1006794B1 (en) 1997-03-12 2007-11-28 Robert W. Esmond A method for treating or preventing alzheimer's disease
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1238661A1 (en) 1999-10-12 2002-09-11 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
CN1188111C (zh) 1999-10-29 2005-02-09 耐科塔医药公司 分散性得到改进的干粉组合物
AU2001230533A1 (en) * 2000-02-04 2001-08-14 Kissei Pharmaceutical Co. Ltd. Powdered preparation for inhalation and powder inhalant containing the same packed
MXPA02008403A (es) 2000-02-28 2004-09-27 Vectura Ltd Mejoras en o relacionadas con el suministro de farmacos por via oral.
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001269261B2 (en) * 2000-06-27 2005-11-17 Vectura Limited Method of making particles for use in a pharmaceutical composition
PT1296651E (pt) * 2000-06-27 2008-02-12 Vectura Ltd Método para fazer partículas para serem usadas numa composição farmacêutica
EP2298285A3 (en) 2000-11-30 2011-07-27 Vectura Limited Method of making particles for use in a pharmaceutical composition
US8580306B2 (en) * 2000-11-30 2013-11-12 Vectura Limited Particles for use in a pharmaceutical composition
EP1345629A2 (en) 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
WO2003020197A1 (en) 2001-09-05 2003-03-13 Vectura Limited Improvements in or relating to the delivery of oral drugs
PT1455755E (pt) 2001-11-20 2013-06-18 Civitas Therapeutics Inc Composições particuladas melhoradas para distribuição pulmonar
KR100958235B1 (ko) 2001-12-19 2010-05-17 노바르티스 아게 아미노글리코시드의 폐 전달
JP2005527508A (ja) 2002-03-07 2005-09-15 ヴェクトゥラ リミテッド 経口デリバリー用急速溶融多粒子製剤
ATE385193T1 (de) 2002-03-20 2008-02-15 Mannkind Corp Inhalationsgerät
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
MXPA05010379A (es) 2003-03-27 2006-05-31 Bioactis Ltd Aparato para administrar una medicina en polvo en la cavidad intranasal.
ITMI20040795A1 (it) * 2004-04-23 2004-07-23 Eratech S R L Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa
EP1785145A4 (en) 2004-08-10 2008-08-13 Translational Res Ltd TRANSNASAL COMPOSITION WITH IMMEDIATE EFFECT AND HIGH RESORBIBILITY
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
KR20150039211A (ko) 2004-08-23 2015-04-09 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
EP1657278A1 (en) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Coated particles of calcium carbonate having a high specific surface
WO2007033372A2 (en) 2005-09-14 2007-03-22 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US20070172430A1 (en) * 2006-01-20 2007-07-26 Nastech Pharmaceutical Company Inc. Dry powder compositions for rna influenza therapeutics
MX360812B (es) 2006-02-22 2018-11-16 Mannkind Corp Un método para mejorar las propiedades farmacéuticas de micropartículas que contienen dicetopiperazina y un agente activo.
US8337817B2 (en) 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
MX395141B (es) 2008-06-13 2025-03-24 Mannkind Corp Inhalador de polvo y sistema para suministro de farmaco.
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CA2728523C (en) 2008-06-20 2020-03-10 Mannkind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
JP5936353B2 (ja) * 2008-07-18 2016-06-22 プロソニックス リミテッドProsonix Limited フルチカゾン粒子の結晶化度を改善する方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
HUE045917T2 (hu) 2009-02-26 2020-01-28 Glaxo Group Ltd 4-{(lR)-2-[(6-(2-[(2,6-Diklórbenzil)-oxi}-etoxi}-hexil)-amino]-l-hidroxietil}-2-(hidroximetil)-fenolt tartalmazó gyógyszerkészítmények
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
WO2010131486A1 (en) 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
TWI547487B (zh) 2009-06-12 2016-09-01 曼凱公司 具限定比表面積之二酮基哌微粒子
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
RU2571331C1 (ru) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
RU2569776C2 (ru) 2011-04-01 2015-11-27 Маннкайнд Корпорейшн Блистерная упаковка для фармацевтических картриджей
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
BR112015000529B1 (pt) 2012-07-12 2022-01-11 Mannkind Corporation Inalador de pó seco
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
ES2928365T3 (es) 2013-03-15 2022-11-17 Mannkind Corp Composiciones de dicetopiperazina microcristalina, métodos de preparación y uso del mismo
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CA3178819A1 (en) 2020-05-26 2021-12-02 Chuanhai Cao Cannabinoid compositions and dosage forms for intranasal or inhalational delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4916230A (en) * 1984-07-02 1990-04-10 Merck & Co., Inc. Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives

Also Published As

Publication number Publication date
ATE154237T1 (de) 1997-06-15
DE69311556D1 (de) 1997-07-17
AU678379B2 (en) 1997-05-29
GR3024468T3 (en) 1997-11-28
NZ254945A (en) 1996-06-25
IL106665A0 (en) 1993-12-08
WO1994004133A1 (en) 1994-03-03
US5908639A (en) 1999-06-01
ES2106362T3 (es) 1997-11-01
CA2142126C (en) 2007-01-09
IL106665A (en) 1998-02-22
AU4725693A (en) 1994-03-15
CA2142126A1 (en) 1994-03-03
JP3787573B2 (ja) 2006-06-21
GB9217312D0 (en) 1992-09-30
EP0654991B1 (en) 1997-06-11
ZA935943B (en) 1994-06-09
JPH08500109A (ja) 1996-01-09
DE69311556T2 (de) 1997-12-04
EP0654991A1 (en) 1995-05-31
MX9304975A (es) 1994-05-31
GB2269992A (en) 1994-03-02

Similar Documents

Publication Publication Date Title
ATE154237T1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
DE69417232D1 (de) Intravaginales wirkstoffabgabesystem
FI954098A0 (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
ES2128411T3 (es) Inhalador de polvo con soportes de polvo con microestructuras regulares.
NO911260D0 (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
FI952976A7 (fi) Inhalaattori jauhemaisia lääkkeitä varten
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
EP0446636A3 (en) External application base or auxiliary agent and external application composition for human being or animal containing the same
NZ237790A (en) Substituted benzimidazoles and medicaments.
MY131774A (en) Coated pesticidal agents, processes for their preparation and compositions containing them
FI915543A7 (fi) Pulverinhalator.
BG103677A (en) Solid mixtures based on sulphonylcarbamides and adjuvants
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
FI955730L (fi) Lääkeaineen jakamiskoostumus alfa-adeno-reseptoreita estäville aineille
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
GR850831B (da)
NO985079L (no) Eksplosiv formulering
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
AU7467994A (en) Novel polysaccharide and radioprotective agent containing the same as active ingredient
GB9010570D0 (en) Agent,and method,for preventing drift of dust
ZA917367B (en) Pharmacologically active compounds and use.
HRP940696B1 (en) Isoxazole-4-carboxamides and hydroxyalkyllidene-cyanoacetamides, drugs containing these compounds and use of such drugs
BG101119A (en) Analgesic composition
SI0731695T1 (en) Pflaster containing an active substance